Computer And Related Services Tenders

Medicines with the Active Ingredient Lanthanum (Iii) Carbonate (Atc: V03ae03 - in the Dosage Form Chewable Tablets)

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Naloxegol, Atc A06ah03 (Obo) for the Period August 1St, 2024 - July 31St, 2026

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Pomalidomide, Atc L04ax06 (Obg) for the Period August 1St, 2024 - July 31St, 2026

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Colistin, Atc J01xb01 (Obg) for the Period August 1St, 2024 - July 31St, 2026

In-House Award According to Art. 5 Para. 1 Regulation (Ec) No. 1370/2007, Section 108 Gwb of a Public Service Contract According to Art. 3 Para. 1 Regulation (Ec) No. 1370/2007 on Public Passenger Transport...

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Ustekinumab, Atc L04ac05 (Obo) for the Period August 1St, 2024 - July 31St, 2025 (Plus Extension Option 1X12 Months)

Construction and Maintenance of a Hydrogen Production System (Consisting of at Least Two Pem Electrolysis Systems with a Total Nominal Output 5 Mw), Including Detailed Engineering

Delivery of Passenger Stairs

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Bimatoprost + Timolol (Exclusively Edo), Atc S01ed62 (Obo) for the Period August 1St, 2024 - July 31St, 2026

Open House Drug Discount Agreements Ustekinumab, Atc L04ac05